Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00112229
Status:
COMPLETED
Last Update Posted:
2013-04-22
First Post:
2005-05-31
Brief Title:
Immunotherapy of HLA-A2 Positive Stage IIIIV Melanoma Patients
Sponsor:
Centre Hospitalier Universitaire Vaudois
Organization:
Centre Hospitalier Universitaire Vaudois
Organization Data
Organization:
Centre Hospitalier Universitaire Vaudois
Class:
OTHER
Study ID:
LUD 2000-018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Centre Hospitalier Universitaire Vaudois
Lead Sponsor Class:
OTHER
Responsible Party:
Prof Olivier Michielin MD PhD
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Centre Hospitalier Universitaire Vaudois
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Ludwig Institute for Cancer Research | OTHER |